Immunovant R&D Day presentation filed; details not fully available in text

Immunovant, Inc.

Immunovant hosted a virtual R&D Day on March 30, 2022; presentation filed as Exhibit 99.1.
The filed exhibit contains only the title slide; no specific data or updates are extractable from the provided text.
Investors should refer to the complete presentation for pipeline and clinical trial updates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.